NCAPG2 and neoplasm: We further integrated QUANTISEQ, EPIC, and TIMER, three well-established algorithms designed to assess cross-tumor immune scoring, to assess the correlation between NCAPG2 expression and immune cell levels, building on the analysis of immune infiltration.